# Intranasal Ketorolac for Postsurgical Pain in Dental Implant Patients

> **NCT01490931** · PHASE4 · COMPLETED · sponsor: **Hersh, Elliot V., DMD, MS, PhD** · enrollment: 28 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Ketorolac Nasal Spray

## Key facts

- **NCT ID:** NCT01490931
- **Lead sponsor:** Hersh, Elliot V., DMD, MS, PhD
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490931, "Intranasal Ketorolac for Postsurgical Pain in Dental Implant Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01490931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*